However, data from an independent GBM cohort indicated that MHC-I repression was more associated with loss of TP53 expression, and neither p53 expression nor MHC-I status significantly influenced progression in Grade 4 astrocytoma [39]. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).